Xianjun Yu

68PUBLICATIONS

84CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyPredictive and prognostic markersCancer cell biology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (68)

Sort by Publication Date:

|Jul 06, 2026

Laparoscopic versus open pancreaticoduodenectomy for non-pancreatic periampullary adenocarcinomas: study protocol for a multicentre randomised controlled trial in China.

|Jun 02, 2026

The emerging role of disulfidptosis in metabolic synergistic death and cancer immunotherapy.

|May 28, 2026

Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in pancreatic cancer.

|Apr 13, 2026

Vorinostat Potentiates Chemoimmunotherapy in Immune-Enriched Pancreatic Cancer.

Chen Chen, Dingru Li, Yingna Liao

|Jan 06, 2026

Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition.

Di Wu, Chunbin Zhu, Haoqi Pan

|Dec 20, 2025

A phase 1b/2 study of first-line anti-PD-L1/ TGF-βRII fusion protein SHR-1701 combined with nab-paclitaxel and gemcitabine for advanced pancreatic ductal adenocarcinoma.

Ran Xue, Miaoyan Wei, Jiajia Yuan

Pageof 12

Frequent Collaborators

14 joint publications

Si Shi

Xiaowu Xu

Yi Qin

Chen Liu

Zhen Tan

Shunrong Ji

Chen Liang

Jin Xu

Wuhu Zhang

Liang Liu

Frequent Collaborators

14 joint publications

Si Shi

9 joint publications

Xiaowu Xu

6 joint publications

Yi Qin

5 joint publications

Chen Liu